Bill.com (BILL) Rises 15% On Narrower Loss, 'Transformative' Divvy Acquisition

Bill.com Holdings Inc. (BILL) PT Raised to $195 at Wolfe Research

Wolfe Research analyst Darrin Peller raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $195.00 (from $185.00) while maintaining a Outperform rating.... More

Bill.com Holdings Inc. (BILL) PT Raised to $180 at Piper Sandler

Piper Sandler analyst Brent Bracelin raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $180.00 (from $170.00) while maintaining a Overweight rating.... More

Pre-Open Stock Movers 05/07: (IBIO) (BILL) (AXON) Higher; (CCIX) (APPN) (FROG) Lower (more...)

Pre-Open Stock Movers

ChemoCentryx, Inc., (Nasdaq: CCXI) 55.8% LOWER; mixed vote from FDA Arthritis Advisory Committee on avacopan for the treatment of Antineutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (or AAV). Multiple analyst downgrades.

iBio, Inc. (NYSE: IBIO) 43% HIGHER; provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.

Bill.com (NYSE:... More

Bill.com Holdings Inc. (BILL) PT Raised to $175 at KeyBanc

KeyBanc analyst Josh Beck raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $175.00 (from $165.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 05/06: (IBIO) (BILL) (AXON) Higher; (APPN) (STMP) (FROG) Lower (more...)

After-Hours Stock Movers

iBio, Inc. (NYSE: IBIO) 43% HIGHER; provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.

Bill.com (NYSE: BILL) 15% HIGHER; reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $54.6 million. Entered into a definitive agreement to acquire Divvy in a stock and cash transaction valued at... More

Bill.com (BILL) to Acquire Divvy for $2.5B

Bill.com (NYSE: BILL) announced it has entered into a definitive agreement to acquire Divvy in a stock and cash transaction valued at approximately $2.5 billion. Divvy is a leader in spend management that modernizes finance for business by combining expense management software and smart corporate cards into a single platform.

The acquisition supports Bill.coms mission and enhances our ability to deliver value to the combined customer base. Bill.coms expanded solution will enable businesses to automatically manage accounts payable, accounts receivable, and corporate card spend all in one place,... More

Bill.com (BILL) Tops Q3 EPS by 5c

Bill.com (NYSE: BILL) reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $54.6 million.

GUIDANCE:

Bill.com sees Q4 2021 EPS of ($0.05)-($0.04), versus the consensus of... More